Date Filed | Type | Description |
10/03/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Paid exercise price by delivering 2,453 shares
@ $0.662, valued at
$1.6k
Exercised 31,250 restricted stock units
@ $0 |
|
08/15/2023 |
SC 13D/A
| Wagner Paul A. reports a 5.2% stake in Forte Biosciences, Inc. |
08/02/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Granted 247,524 shares
@ $1.01, valued at
$250k
|
|
07/05/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Paid exercise price by delivering 2,453 shares
@ $1.04, valued at
$2.6k
Exercised 31,250 restricted stock units
@ $0 |
|
04/04/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Paid exercise price by delivering 11,046 shares
@ $1.01, valued at
$11.2k
Exercised 31,250 restricted stock units
@ $0 |
|
03/23/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Granted 500,000 restricted stock units
@ $0 |
|
12/19/2022 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Bought 55,976 shares
@ $1.0303, valued at
$57.7k
Bought 44,024 shares
@ $1.0676, valued at
$47k
|
|
05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2022 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.
Txns:
| Granted 300,000 options to buy
@ $1.72, valued at
$516k
|
|
09/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
SC 13D
| Wagner Paul A. reports a 21% stake in Forte Biosciences, Inc. |
06/17/2020 |
3
| Wagner Paul A. (See Remarks) has filed a Form 3 on Forte Biosciences, Inc. |
03/16/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |